WILLIAM MULLIGAN: Open Payments
NPI 1023868999 · VALDOSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,413 in 60 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $1,161 · 2025 $1,413
Food & beverage: $1,413
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 15 | $306 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $249 |
| Merck Sharp & Dohme LLC | 10 | $182 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $177 |
| AstraZeneca Pharmaceuticals LP | 4 | $69 |
| Medtronic, Inc. | 2 | $66 |
| Alnylam Pharmaceuticals Inc. | 3 | $59 |
| Amgen Inc. | 4 | $56 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $51 |
| Abbott Laboratories | 1 | $50 |
Products named: LifeVest, CAMZYOS, JARDIANCE, VERQUVO, ELIQUIS, AMVUTTRA, REPATHA, FARXIGA.
Industry payments across GA — which companies pay providers there.
